- Home
- GLU vs PSNL Comparison
GLU vs PSNL Comparison
Compare GLU & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GLU | PSNL |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 746.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GLU | PSNL |
|---|---|---|
| Price | $19.43 | $8.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $10.71 |
| AVG Volume (30 Days) | 12.4K | ★ 1.5M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 8.60% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | N/A | ★ $69,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.33 |
| P/E Ratio | $22.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.61 | $2.83 |
| 52 Week High | $15.40 | $11.40 |
Technical Indicators
Market Signals| Indicator | GLU | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 64.13 | 43.50 |
| Support Level | $18.36 | $7.68 |
| Resistance Level | $20.13 | $9.10 |
| Average True Range (ATR) | 0.27 | 0.48 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 60.62 | 22.85 |
Price Performance
Historical ComparisonAbout GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.